A randomized, double-blind, multicenter phase 2 trial of denosumab in combination with chemotherapy as first-line treatment of metastatic non-small cell lung cancer
Publication
, Conference
Seigel, DR; Hirsch, FR; De Boer, RH; Natale, RB; Crawford, J; Weiss, GJ; Glaspy, JA; Fang, A; Braun, A; Jain, RK
Published in: JOURNAL OF CLINICAL ONCOLOGY
May 20, 2014
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2014
Volume
32
Issue
15
Location
Chicago, IL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
50th Annual Meeting of the American-Society-of-Clinical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Seigel, D. R., Hirsch, F. R., De Boer, R. H., Natale, R. B., Crawford, J., Weiss, G. J., … Jain, R. K. (2014). A randomized, double-blind, multicenter phase 2 trial of denosumab in combination with chemotherapy as first-line treatment of metastatic non-small cell lung cancer. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 32). Chicago, IL: AMER SOC CLINICAL ONCOLOGY.
Seigel, David R., Fred R. Hirsch, Richard H. De Boer, Ronald B. Natale, Jeffrey Crawford, Glen J. Weiss, John A. Glaspy, Amy Fang, Ada Braun, and Rajul K. Jain. “A randomized, double-blind, multicenter phase 2 trial of denosumab in combination with chemotherapy as first-line treatment of metastatic non-small cell lung cancer.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 32. AMER SOC CLINICAL ONCOLOGY, 2014.
Seigel DR, Hirsch FR, De Boer RH, Natale RB, Crawford J, Weiss GJ, et al. A randomized, double-blind, multicenter phase 2 trial of denosumab in combination with chemotherapy as first-line treatment of metastatic non-small cell lung cancer. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2014.
Seigel, David R., et al. “A randomized, double-blind, multicenter phase 2 trial of denosumab in combination with chemotherapy as first-line treatment of metastatic non-small cell lung cancer.” JOURNAL OF CLINICAL ONCOLOGY, vol. 32, no. 15, AMER SOC CLINICAL ONCOLOGY, 2014.
Seigel DR, Hirsch FR, De Boer RH, Natale RB, Crawford J, Weiss GJ, Glaspy JA, Fang A, Braun A, Jain RK. A randomized, double-blind, multicenter phase 2 trial of denosumab in combination with chemotherapy as first-line treatment of metastatic non-small cell lung cancer. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2014.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2014
Volume
32
Issue
15
Location
Chicago, IL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
50th Annual Meeting of the American-Society-of-Clinical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences